Myopathy with concurrent tadalafil and simvastatin
- PMID: 19721707
- PMCID: PMC2728614
- DOI: 10.1155/2009/378287
Myopathy with concurrent tadalafil and simvastatin
Abstract
A 48-year-old man, using statin, was admitted to hospital with progressive myalgia after consumption of tadalafil and simvastatin. Muscle pain and penile erection disappeared seven days after interruption of therapy. This case demonstrates the interaction of tadalafil with simvastatin resulting in myopathy. Muscle damage could be attributed to the common metabolic way of these two drugs which is cytochrome P450 isoenzyme system.
Similar articles
-
Rhabdomyolysis induced by rosuvastatin and sildenafil.South Med J. 2010 Oct;103(10):1052-4. doi: 10.1097/SMJ.0b013e3181f0e89c. South Med J. 2010. PMID: 20818298
-
Rhabdomyolysis in association with simvastatin and amiodarone.Ann Pharmacother. 2004 Jun;38(6):978-81. doi: 10.1345/aph.1D498. Epub 2004 Apr 6. Ann Pharmacother. 2004. PMID: 15069169
-
A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.Atherosclerosis. 2015 Feb;238(2):329-35. doi: 10.1016/j.atherosclerosis.2014.12.016. Epub 2014 Dec 17. Atherosclerosis. 2015. PMID: 25545331 Free PMC article. Clinical Trial.
-
Does simvastatin cause more myotoxicity compared with other statins?Ann Pharmacother. 2009 Dec;43(12):2012-20. doi: 10.1345/aph.1M410. Epub 2009 Nov 17. Ann Pharmacother. 2009. PMID: 19920157 Review.
-
A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis.Pharmacotherapy. 2006 Mar;26(3):414-22. doi: 10.1592/phco.26.3.414. Pharmacotherapy. 2006. PMID: 16503723 Review.
References
-
- Kendirci M, Nowfar S, Hellstrom WJ. The impact of vascular risk factors on erectile function. Drugs of Today. 2005;41(1):65–74. - PubMed
-
- Ring BJ, Patterson BE, Mitchell MI, et al. Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo. Clinical Pharmacology and Therapeutics. 2005;77(1):63–75. - PubMed
-
- Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with Tadalafil improves endothelial function in men with increased cardiovascular risk. European Urology. 2005;47(2):214–222. - PubMed
-
- Solomon H, Wierzbicki AS, Lumb PJ, Lambert-Hammill M, Jackson G. Cardiovascular risk factors determine erectile and arterial function response to Sildenafil. American Journal of Hypertension. 2006;19(9):915–919. - PubMed
Publication types
LinkOut - more resources
Full Text Sources